DR4 MEF, P2, untreated, 1 vial of 1
Order now: dominika@ksiazkiwnauce.pl
 DR4 MEF, P3, mitomycin-C treated, 1 vial of 4^106 cells |
|
ASF-1023 |
Applied StemCell |
1 vial of 4 x 10^6 cells |
EUR 89.69 |
|
Description: 6 month |
 DR4 MEF, P3, mitomycin-C treated, 1 vial of 2^106 cells |
|
ASF-1025 |
Applied StemCell |
1 vial of 2 x 10^6 cells |
EUR 73.31 |
|
Description: 6 month |
 DR4 MEF, P3, irradiated, 5 vial of 2^106 cells |
|
ASF-1016 |
Applied StemCell |
5 vials of 2 x 10^6 cells |
EUR 157.73 |
|
Description: 6 month |
 DR4 MEF, P3, mitomycin-C treated, 5 vial of 2^106 cells |
|
ASF-1026 |
Applied StemCell |
5 vials of 2 x 10^6 cells |
EUR 157.73 |
|
Description: 6 month |
 CF1 MEF, P3, irradiated, 1 vial of 1^106 cells |
|
ASF-1217 |
Applied StemCell |
1 vial of 1 x 10^6 cells |
EUR 57.56 |
|
Description: 6 month |
 CORNING® UNTREATED MICROCARRIERS, 1 VIAL, 100 G |
|
4624 |
CORNING |
100g/pk |
EUR 698 |
|
Description: Microcarriers; Corning Microcarriers |
 CORNING® UNTREATED MICROCARRIERS, 1 VIAL, 10 G |
|
3772 |
CORNING |
10g/pk |
EUR 98 |
|
Description: Microcarriers; Corning Microcarriers |
 CF1 MEF, P3, irradiated, 1 vial of 4^106 cells |
|
ASF-1213 |
Applied StemCell |
1 vial of 4 x 10^6 cells |
EUR 65.12 |
|
Description: 6 month |
 CF1 MEF, P3, irradiated, 1 vial of 2^106 cells |
|
ASF-1215 |
Applied StemCell |
1 vial of 2 x 10^6 cells |
EUR 61.66 |
|
Description: 6 month |
 Neo resistant MEF, P3, irradiated, 1 vial of 4^106 cells |
|
ASF-1113 |
Applied StemCell |
1 vial of 4 x 10^6 cells |
EUR 65.12 |
|
Description: 6 month |
 Neo resistant MEF, P3, irradiated, 1 vial of 2^106 cells |
|
ASF-1115 |
Applied StemCell |
1 vial of 2 x 10^6 cells |
EUR 61.66 |
|
Description: 6 month |
 CF1 MEF, P3, mitomycin-C treated, 1 vial of 4^106 cells |
|
ASF-1223 |
Applied StemCell |
1 vial of 4 x 10^6 cells |
EUR 65.12 |
|
Description: 6 month |
 CF1 MEF, P3, mitomycin-C treated, 1 vial of 2^106 cells |
|
ASF-1225 |
Applied StemCell |
1 vial of 2 x 10^6 cells |
EUR 61.66 |
|
Description: 6 month |
 Neo resistant MEF, P3, mitomycin-C treated, 1 vial of 4^106 cells |
|
ASF-1123 |
Applied StemCell |
1 vial of 4 x 10^6 cells |
EUR 65.12 |
|
Description: 6 month |
 Neo resistant MEF, P3, mitomycin-C treated, 1 vial of 2^106 cells |
|
ASF-1125 |
Applied StemCell |
1 vial of 2 x 10^6 cells |
EUR 61.66 |
|
Description: 6 month |
 DR4 MEF, P3, irradiated, 5 vials of 4^106 cells |
|
ASF-1014 |
Applied StemCell |
5 vials of 4 x 10^6 cells |
EUR 232.07 |
|
Description: 6 month |
 DR4 MEF, P3, mitomycin-C treated, 5 vials of 4^106 cells |
|
ASF-1024 |
Applied StemCell |
5 vials of 4 x 10^6 cells |
EUR 232.07 |
|
Description: 6 month |
) PiranhaTM HEK293T GFP/Puromycin Stable Cell Line (>1x10^6 cell/vial) |
|
PTPD600A-1 |
SBI |
1 vial |
EUR 1132 |
) Rat/Mouse Myelin Oligodendrocyte Glycoprotein 35-55 aa peptide pure (Ac/amide form) |
|
MOG3555-P2-1 |
Alpha Diagnostics |
1 mg |
EUR 286 |
 AssayMax ELISA Kit) Human Inhibitor of Growth Protein 1 (ING1) AssayMax ELISA Kit |
|
EI1770-1 |
AssayPro |
96 Well Plate |
EUR 477 |
 TIMP1 Human, Tissue Inhibitor of Metalloprotease 1 Human Recombinant Protein, HEK |
|
PROTP01033-1 |
BosterBio |
Regular: 10ug |
EUR 317 |
|
Description: TIMP1 Human Recombinant produced in HEK-293 cells is a secreted protein with the sequence of Human TIMP-1 (amino acids Cys24-Ala207) and fused to a polyhistidine tag at the C-terminus. |
 for BCA Optima Protein Assay kit) BSA and BGG Stock standards (1 vial each @ 2 mg/ml) for BCA Optima Protein Assay kit |
|
BSA-BGG-1 |
Alpha Diagnostics |
1 pk |
EUR 286 |
.) Saponins vaccine adjuvant Combo Pak-1 (contains 1mg of QS21,100 mg of Vet-SAP and 1 g of Saponin). |
|
AV-4000-PK-1 |
Alpha Diagnostics |
1 pk |
EUR 529 |
) Custom production of antibodies in 1 Goat using supplied antigen (std 63 days protocol) |
|
GOT-1 |
Alpha Diagnostics |
1 |
EUR 1877 |
) Custom production of antibodies in 1 Rabbit using supplied antigen (std 63 days protocol) |
|
RAB-1 |
Alpha Diagnostics |
1 |
EUR 659 |
) Custom production of antibodies in 1 Sheep using supplied antigen (std 63 days protocol) |
|
SHP-1 |
Alpha Diagnostics |
1 |
EUR 1877 |
 GYRKPLDNIKDNVGKMEDYIKK, MSP-1 P2, peptide of P. falciparum Merozoite Surface Protein 1 |
|
MSPF12-P |
Alpha Diagnostics |
1 mg |
EUR 225 |
, human recombinant protein) Neuregulin/Heregulin-1? (NRG-1?/HRG-1?), human recombinant protein |
|
P1054-1 |
ApexBio |
1 mg |
EUR 3947 |
|
Description: Neuregulin (NRG) is a signaling protein for ErbB2/ErbB4 receptor heterodimers on the cardiac muscle cells and plays an important role in heart structure and function through inducing cardiomyocyte differentiation |
 sTRAIL Receptor-1/DR4, human recombinant |
|
7206-10 |
Biovision |
|
EUR 153 |
sTRAIL Receptor-1/DR4, human recombinant |
|
7206-50 |
Biovision |
|
EUR 381 |
 Human Plasma) Haptoglobin, (Phenotype 1-1) Human Plasma |
|
7536-1 |
Biovision |
|
EUR 321 |
 amide) Angiotensin 1/2 (1-7) amide |
|
A1054-1 |
ApexBio |
1 mg |
EUR 96 |
|
Description: Angiotensin I/II (1-7) amide (H2N-Asp-Arg-Val-Tyr-Ile-His-Pro-amide) is a peptide analog to angiotensin II that is used as a vasopressor in the treatment of certain types of shock and circulatory collapse. |
 amide) Angiotensin 1/2 (1-8) amide |
|
A1055-1 |
ApexBio |
1 mg |
EUR 96 |
|
Description: The physiologically active peptide angiotensin-2 (angiotensin 1- 8) is yielded from angiotensin-1, a substrate of ACE (angiotensin converting enzyme), by removing a dipeptide. |
, amide, human) Endothelin-1 (1-15), amide, human |
|
A1111-1 |
ApexBio |
1 mg |
EUR 722 |
|
Description: Endothelins are 21-amino acid vasoconstricting peptides produced primarily in the endothelium and have a key role in vascular homeostasis. |
DR4 MEF, P2, untreated, 1 vial of 1
